PharmaResources (Shanghai) Co., Ltd. (SHE:301230)

China · Delayed Price · Currency is CNY

26.75

+2.27 (9.27%)

At close: Aug 4, 2026

-8.27% (1Y)

Market Cap	4.78B -8.3%
Revenue (ttm)	691.21M +18.5%
Net Income	46.10M +81.6%
EPS	0.25 +70.8%
Shares Out	178.80M
PE Ratio	109.07
Forward PE	79.03
Dividend	0.28 (1.16%)
Ex-Dividend Date	Jul 16, 2026

Volume	16,255,834
Open	25.00
Previous Close	24.48
Day's Range	25.00 - 26.93
52-Week Range	22.23 - 52.29
Beta	0.89
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About SHE:301230

PharmaResources (Shanghai) Co., Ltd., together with its subsidiaries, operates as a one-stop integrated service provider for new drug research, development, and commercial manufacturing to pharmaceutical and biotechnology companies in China and internationally. The company offers contract research organization (CRO), contract manufacturing organization (CMO), contract development and manufacturing organization (CDMO), and commercial manufacturing services for small molecule drugs. It is also involved in the research, development, and customized... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2007

Employees 1,155

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 301230

Full Company Profile

Financial Performance

In 2025, SHE:301230's revenue was 688.35 million, an increase of 26.43% compared to the previous year's 544.47 million. Earnings were 34.29 million, an increase of 100.75%.

Financial Statements